Pro Share Advisors LLC Atea Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 19,570 shares of AVIR stock, worth $63,602. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,570

Previous 15,466 26.54%

Holding current value

$63,602

Previous $51,000 27.45%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.17 - $4.02 $13,009 - $16,498	4,104 Added 26.54%	19,570 $65,000
Q2 2024 Aug 13, 2024	SELL	$3.31 - $4.04 $13,918 - $16,988	-4,205 Reduced 21.38%	15,466 $51,000
Q1 2024 May 08, 2024	BUY	$3.09 - $4.56 $5,101 - $7,528	1,651 Added 9.16%	19,671 $79,000
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $7,305 - $8,740	2,609 Added 16.93%	18,020 $54,000
Q3 2023 Nov 13, 2023	BUY	$3.0 - $3.79 $135 - $170	45 Added 0.29%	15,411 $46,000
Q2 2023 Aug 10, 2023	BUY	$3.21 - $5.06 $1,948 - $3,071	607 Added 4.11%	15,366 $57,000
Q1 2023 May 11, 2023	SELL	$3.0 - $4.97 $5,844 - $9,681	-1,948 Reduced 11.66%	14,759 $49,000
Q4 2022 Feb 02, 2023	BUY	$4.35 - $6.17 $5,615 - $7,965	1,291 Added 8.37%	16,707 $80,000
Q3 2022 Nov 04, 2022	BUY	$5.49 - $8.79 $1,981 - $3,173	361 Added 2.4%	15,416 $88,000
Q2 2022 Aug 01, 2022	SELL	$5.33 - $8.18 $30,199 - $46,347	-5,666 Reduced 27.34%	15,055 $108,000
Q1 2022 May 10, 2022	SELL	$5.5 - $9.19 $28,072 - $46,905	-5,104 Reduced 19.76%	20,721 $150,000
Q4 2021 Feb 08, 2022	BUY	$7.67 - $44.59 $134,616 - $782,599	17,551 Added 212.12%	25,825 $231,000
Q3 2021 Nov 12, 2021	SELL	$21.33 - $35.06 $190,455 - $313,050	-8,929 Reduced 51.9%	8,274 $290,000
Q2 2021 Aug 13, 2021	BUY	$19.22 - $59.08 $251,724 - $773,770	13,097 Added 318.97%	17,203 $370,000
Q1 2021 May 14, 2021	BUY	$41.42 - $88.44 $170,070 - $363,134	4,106 New	4,106 $254,000

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $271M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Atea Pharmaceuticals, Inc. Transaction History